發送短信 : Tumor response and health-related quality of life in clinically selected patients from Asia with advanced non-small-cell lung cancer treated with first-line gefitinib: Post hoc analyses from the IPASS study

  ______    _____                ___      ______  
 /_   _//  |  ___||     ___     / _ \\   /_____// 
   | ||    | ||__      /   ||  | / \ ||  `____ `  
  _| ||    | ||__     | [] ||  | \_/ ||  /___//   
 /__//     |_____||    \__ ||   \___//   `__ `    
 `--`      `-----`      -|_||   `---`    /_//     
                         `-`             `-`